QLS5316

QLS5316 · Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QLS5316, covering 2026-01-22 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: First in Human Study of QLS5316 in Solid Tumors [Phase 1]